We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$25.4B
1-Year Est. Return
38.46%
This Fund
S&P 500
This Quarter
Est. Return
+13.16%
1 Year Est. Return
+38.46%
3 Year Est. Return
+154.38%
5 Year Est. Return
+223.79%
10 Year Est. Return
+923.25%
AUM
$22.5B
AUM Growth
+$1.93B
(+9.4%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
26.61%
Holding
1,346
New
164
Increased
337
Reduced
605
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$426M |
| 2 |
Deere & Co
DE
|
+$212M |
| 3 |
NVIDIA
NVDA
|
+$149M |
| 4 |
W.W. Grainger
GWW
|
+$140M |
| 5 |
Netflix
NFLX
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$196M |
| 2 |
Home Depot
HD
|
+$189M |
| 3 |
Gilead Sciences
GILD
|
+$145M |
| 4 |
Oracle
ORCL
|
+$145M |
| 5 |
Microsoft
MSFT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.24% |
| 2 | Financials | 13.5% |
| 3 | Healthcare | 12.02% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Industrials | 11.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Toll Brothers
TOL
$13.9B
| $50.7M | 0.22% |
844,029
+145,604
| +21% | +$8.4M |
|
102
Roper Technologies
ROP
$39.1B
| $50.5M | 0.22% |
114,624
+92,361
| +415% | +$39.9M |
|
|
HOLX
103
DELISTED
Hologic
HOLX
| $50.5M | 0.22% |
625,429
+189,505
| +43% | +$15.3M |
|
104
Teradata
TDC
$2.49B
| $49.3M | 0.22% |
+1,225,017
| New | +$45.5M |
|
105
Monster Beverage
MNST
$90.1B
| $48.9M | 0.22% |
1,811,184
+782,356
| +76% | +$20.1M |
|
106
ConocoPhillips
COP
$153B
| $48.7M | 0.22% |
491,252
-124,847
| -20% | -$13.7M |
|
107
Expedia Group
EXPE
$39.1B
| $48.5M | 0.22% |
500,298
+390,970
| +358% | +$41M |
|
108
West Pharmaceutical
WST
$24.8B
| $48.5M | 0.22% |
140,034
+136,586
| +3,961% | +$39.9M |
|
109
Bath & Body Works
BBWI
$3.65B
| $48.1M | 0.21% |
1,315,905
+653,855
| +99% | +$27.4M |
|
110
Nike
NKE
$60.1B
| $47.9M | 0.21% |
390,640
+361,537
| +1,242% | +$44.4M |
|
111
TJX Companies
TJX
$169B
| $47.7M | 0.21% |
608,569
-188,632
| -24% | -$14.8M |
|
112
Sysco
SYY
$40.5B
| $47.5M | 0.21% |
615,467
-594,385
| -49% | -$45.6M |
|
113
Incyte
INCY
$24.5B
| $46.8M | 0.21% |
647,422
+15,230
| +2% | +$1.19M |
|
114
Corpay
CPAY
$26.9B
| $46.3M | 0.21% |
219,492
+12,366
| +6% | +$2.51M |
|
115
Centene
CNC
$33.1B
| $45.8M | 0.2% |
724,363
+365,947
| +102% | +$26M |
|
116
Costco
COST
$421B
| $45.4M | 0.2% |
91,350
-55,767
| -38% | -$27.4M |
|
117
Mettler-Toledo International
MTD
$28.8B
| $44.4M | 0.2% |
29,037
+2,459
| +9% | +$3.69M |
|
118
Align Technology
ALGN
$12.4B
| $44.4M | 0.2% |
132,878
+62,699
| +89% | +$18.5M |
|
|
119
Gilead Sciences
GILD
$168B
| $44M | 0.2% |
530,080
-1,755,157
| -77% | -$145M |
|
120
Xylem
XYL
$28.5B
| $44M | 0.2% |
+419,993
| New | +$43.9M |
|
121
Texas Instruments
TXN
$253B
| $43.8M | 0.19% |
235,394
-15,740
| -6% | -$2.77M |
|
122
3M
MMM
$94.8B
| $43.5M | 0.19% |
495,144
+146,435
| +42% | +$13.8M |
|
123
Lamb Weston
LW
$7.3B
| $43.4M | 0.19% |
415,358
-7,282
| -2% | -$720K |
|
124
Pultegroup
PHM
$24.6B
| $43.1M | 0.19% |
+740,059
| New | +$40M |
|
125
Microchip Technology
MCHP
$43.1B
| $43.1M | 0.19% |
513,863
+174,600
| +51% | +$13.9M |
|
Similar funds
VAI
Los Angeles Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Los Angeles Capital Management held 1,346 positions worth $22.5B, up 9.4% from $20.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Los Angeles Capital Management's Q1 2023 filing shows 164 new, 337 increased, 605 reduced and 194 closed positions. Its largest new stake was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M. The largest sale was Pfizer, an estimated $196M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- Los Angeles Capital Management's largest Q1 2023 buy was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M.
- Los Angeles Capital Management added most to Visa in Q1 2023, an estimated $426M increase.
- Los Angeles Capital Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $196M.
- Los Angeles Capital Management fully exited Regions Financial in Q1 2023, selling an estimated $50.4M.
- Los Angeles Capital Management's ten largest holdings make up 27% of its $22.5B portfolio in Q1 2023.
- Los Angeles Capital Management opened 164 new positions and closed 194 in Q1 2023.
- Los Angeles Capital Management's portfolio value rose 9.4% quarter-over-quarter to $22.5B.
Based on Los Angeles Capital Management's 13F filing for Q1 2023, filed 4 May 2023.